Can a gentle brain zapping schedule ease Parkinson's symptoms?
NCT ID NCT07774312
First seen Aug 19, 2026 · Last updated Aug 21, 2026 · Updated 2 times
Summary
This trial tests whether a non-invasive brain stimulation technique called temporal interference stimulation (tTIS) can improve motor symptoms in people with Parkinson's disease. Participants will receive tTIS either once, twice, or five times a week for two weeks, or continue with standard medication alone. The study aims to see if different stimulation schedules lead to different improvements in movement, and how long any benefits might last.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Transcranial temporal interference stimulation (tTIS) targeting the subthalamic nucleus, delivered via scalp electrodes
- What this could lead to
- If effective, this non-invasive brain stimulation could offer a new way to improve motor symptoms in Parkinson's disease, potentially reducing reliance on medication.
- What could go wrong
- This is an early-stage trial with a small number of participants, and it's unclear if the stimulation will produce meaningful or lasting benefits. There may also be unknown side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2026
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 1.Aged 50-85 years, male or female. * 2.Diagnosed with idiopathic Parkinson disease (PD) in accordance with the Chinese Guidelines for the Diagnosis and Treatment of Parkinson's Disease (4th Edition), with a confirmed diagnosis for at least 6 months and a stable condition, defined as no significant deterioration or major medication adjustment within the past month. * 3.Receiving stable doses of antiparkinsonian medication (e.g., levodopa or dopamine agonists) and willing to maintain the medication regimen during the study. * 4.Hoehn and Yahr stage 1-3 in the medication ON state. * 5.Baseline MDS-UPDRS Part III total score ≥20 in the medication ON state. * 6.No history of non-invasive neuromodulation therapy, or discontinuation of such therapy for at least 3 months before enrollment if previously received. * 7.Normal cognitive function (MoCA score ≥24) and able to cooperate with tTIS intervention, clinical scale assessments, and basic smartphone- and smartwatch-assisted home-based motor self-assessments. * 8.Able and willing to provide written informed consent and complete all required study procedures and follow-up assessments. Exclusion Criteria: * 1.Other neurological disorders that may affect motor or cognitive function. * 2.Contraindications to magnetic resonance imaging (MRI), such as claustrophobia. * 3.History of taking antipsychotics, antidepressants, or other medications affecting dopamine levels. * 4.Psychiatric disorders (e.g., depression or schizophrenia), substance abuse, or alcohol dependence. * 5.Implanted medical devices (e.g., pacemaker or defibrillator), metal implants in the cranium or spine, a personal or family history of epilepsy, or severe skull defects. * 6.Previous deep brain stimulation (DBS) or other intracranial implantation surgery, or participation in another Parkinson disease clinical trial within the past 3 months.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Parkinson's disease (PD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
RECRUITINGShanghai, Shanghai Municipality, 200025, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can brain stimulation be tuned to improve sleep in Parkinson's?
- Can a blood bank unlock the genetics of brain disease?
- Sleep disorder may hold the key to spotting Parkinson's years earlier
- Can a new pill slow Parkinson's symptoms?
- Dancing away Parkinson's symptoms: tango therapy put to the test
- Gentle bowing, calmer mind: music therapy put to the test for Parkinson's anxiety